OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 97 filers reported holding OLEMA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $636,346 | +12.1% | 51,526 | -18.0% | 0.00% | – |
| Q2 2023 | $567,599 | +43.6% | 62,857 | -44.8% | 0.00% | – |
| Q1 2023 | $395,198 | -20.5% | 113,890 | -43.9% | 0.00% | – |
| Q4 2022 | $497,159 | -37.3% | 202,922 | -29.4% | 0.00% | – |
| Q3 2022 | $793,000 | -55.3% | 287,504 | -34.1% | 0.00% | – |
| Q2 2022 | $1,776,000 | -31.1% | 436,432 | -27.9% | 0.00% | – |
| Q1 2022 | $2,579,000 | -53.5% | 605,260 | +2.2% | 0.00% | -100.0% |
| Q4 2021 | $5,544,000 | +133.6% | 592,325 | +587.8% | 0.00% | – |
| Q3 2021 | $2,373,000 | -32.2% | 86,124 | -31.2% | 0.00% | – |
| Q2 2021 | $3,501,000 | +71.6% | 125,160 | +103.7% | 0.00% | – |
| Q1 2021 | $2,040,000 | -7.3% | 61,458 | +34.3% | 0.00% | – |
| Q4 2020 | $2,201,000 | – | 45,768 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $180,006,000 | 15.43% |
| BVF INC/IL | 6,661,503 | $320,285,000 | 12.60% |
| VR Adviser, LLC | 1,536,193 | $73,860,000 | 10.86% |
| Foresite Capital Management IV, LLC | 818,030 | $39,331,000 | 4.27% |
| Cormorant Asset Management, LP | 3,195,544 | $148,169,000 | 3.53% |
| Vivo Capital, LLC | 1,238,575 | $59,551,000 | 2.66% |
| RA Capital Management | 2,150,404 | $103,391,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 696,191 | $33,473,000 | 0.66% |
| Avoro Capital Advisors LLC | 876,986 | $35,646,000 | 0.61% |
| Avidity Partners Management LP | 270,000 | $12,982,000 | 0.42% |